BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Coverdale JPC, Bridgewater HE, Song JI, Smith NA, Barry NPE, Bagley I, Sadler PJ, Romero-Canelón I. In Vivo Selectivity and Localization of Reactive Oxygen Species (ROS) Induction by Osmium Anticancer Complexes That Circumvent Platinum Resistance. J Med Chem 2018;61:9246-55. [PMID: 30230827 DOI: 10.1021/acs.jmedchem.8b00958] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Odularu AT, Yebra-biurrun MC. Manganese Schiff Base Complexes, Crystallographic Studies, Anticancer Activities, and Molecular Docking. Journal of Chemistry 2022;2022:1-19. [DOI: 10.1155/2022/7062912] [Reference Citation Analysis]
2 Bolitho EM, Coverdale JPC, Wolny JA, Schünemann V, Sadler PJ. Density functional theory investigation of Ru(II) and Os(II) asymmetric transfer hydrogenation catalysts. Faraday Discuss 2022. [PMID: 35156974 DOI: 10.1039/d1fd00075f] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wittmann C, Sivchenko AS, Bacher F, Tong KKH, Guru N, Wilson T, Gonzales J, Rauch H, Kossatz S, Reiner T, Babak MV, Arion VB. Inhibition of Microtubule Dynamics in Cancer Cells by Indole-Modified Latonduine Derivatives and Their Metal Complexes. Inorg Chem 2022;61:1456-70. [PMID: 34995063 DOI: 10.1021/acs.inorgchem.1c03154] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Bolitho EM, Worby NG, Coverdale JPC, Wolny JA, Schünemann V, Sadler PJ. Quinone Reduction by Organo-Osmium Half-Sandwich Transfer Hydrogenation Catalysts. Organometallics 2021;40:3012-23. [DOI: 10.1021/acs.organomet.1c00358] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wang CJ, Guo X, Zhai RQ, Sun C, Xiao G, Chen J, Wei MY, Shao CL, Gu Y. Discovery of penipanoid C-inspired 2-(3,4,5-trimethoxybenzoyl)quinazolin-4(3H)-one derivatives as potential anticancer agents by inhibiting cell proliferation and inducing apoptosis in hepatocellular carcinoma cells. Eur J Med Chem 2021;224:113671. [PMID: 34237623 DOI: 10.1016/j.ejmech.2021.113671] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
6 Kladnik J, Coverdale JPC, Kljun J, Burmeister H, Lippman P, Ellis FG, Jones AM, Ott I, Romero-Canelón I, Turel I. Organoruthenium Complexes with Benzo-Fused Pyrithiones Overcome Platinum Resistance in Ovarian Cancer Cells. Cancers (Basel) 2021;13:2493. [PMID: 34065335 DOI: 10.3390/cancers13102493] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
7 Coverdale JPC, Guy CS, Bridgewater HE, Needham RJ, Fullam E, Sadler PJ. Osmium-arene complexes with high potency towards Mycobacterium tuberculosis. Metallomics 2021;13:mfab007. [PMID: 33693931 DOI: 10.1093/mtomcs/mfab007] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Wei Q, Wei Z, Zeng J, Yang L, Qin Q, Tan M, Liang H. Synthesis, structures and anticancer potentials of five platinum(II) complexes with benzothiazole-benzopyran targeting mitochondria. Polyhedron 2021;196:115004. [DOI: 10.1016/j.poly.2020.115004] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Bolitho EM, Coverdale JPC, Bridgewater HE, Clarkson GJ, Quinn PD, Sanchez‐cano C, Sadler PJ. Tracking Reactions of Asymmetric Organo‐Osmium Transfer Hydrogenation Catalysts in Cancer Cells. Angew Chem 2021;133:6536-46. [DOI: 10.1002/ange.202016456] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Bolitho EM, Coverdale JPC, Bridgewater HE, Clarkson GJ, Quinn PD, Sanchez-Cano C, Sadler PJ. Tracking Reactions of Asymmetric Organo-Osmium Transfer Hydrogenation Catalysts in Cancer Cells. Angew Chem Int Ed Engl 2021;60:6462-72. [PMID: 33590607 DOI: 10.1002/anie.202016456] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
11 Bolitho EM, Bridgewater HE, Needham RJ, Coverdale JPC, Quinn PD, Sanchez-cano C, Sadler PJ. Elemental mapping of half-sandwich azopyridine osmium arene complexes in cancer cells. Inorg Chem Front 2021;8:3675-85. [DOI: 10.1039/d1qi00512j] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Ortega E, Ballester FJ, Hernández-garcía A, Hernández-garcía S, Guerrero-rubio MA, Bautista D, Santana MD, Gandía-herrero F, Ruiz J. Novel organo-osmium( ii ) proteosynthesis inhibitors active against human ovarian cancer cells reduce gonad tumor growth in Caenorhabditis elegans. Inorg Chem Front 2021;8:141-55. [DOI: 10.1039/c9qi01704f] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Ballesta A, Billy F, Coverdale JPC, Song JI, Sanchez-Cano C, Romero-Canelón I, Sadler PJ. Kinetic analysis of the accumulation of a half-sandwich organo-osmium pro-drug in cancer cells. Metallomics 2019;11:1648-56. [PMID: 31528927 DOI: 10.1039/c9mt00173e] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
14 Zhang WY, Banerjee S, Hughes GM, Bridgewater HE, Song JI, Breeze BG, Clarkson GJ, Coverdale JPC, Sanchez-Cano C, Ponte F, Sicilia E, Sadler PJ. Ligand-centred redox activation of inert organoiridium anticancer catalysts. Chem Sci 2020;11:5466-80. [PMID: 34094073 DOI: 10.1039/d0sc00897d] [Cited by in Crossref: 6] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
15 Soldevila-Barreda JJ, Azmanova M, Pitto-Barry A, Cooper PA, Shnyder SD, Barry NPE. Preclinical Anticancer Activity of an Electron-Deficient Organoruthenium(II) Complex. ChemMedChem 2020;15:982-7. [PMID: 32237195 DOI: 10.1002/cmdc.202000096] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
16 Khan TA, Bhar K, Thirumoorthi R, Roy TK, Sharma AK. Design, synthesis, characterization and evaluation of the anticancer activity of water-soluble half-sandwich ruthenium( ii ) arene halido complexes. New J Chem 2020;44:239-57. [DOI: 10.1039/c9nj03663f] [Cited by in Crossref: 10] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
17 Li J, Zeng L, Xiong K, Rees TW, Jin C, Wu W, Chen Y, Ji L, Chao H. A biotinylated ruthenium(ii) photosensitizer for tumor-targeted two-photon photodynamic therapy. Chem Commun (Camb) 2019;55:10972-5. [PMID: 31453611 DOI: 10.1039/c9cc05826e] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 6.7] [Reference Citation Analysis]
18 Rubio AR, Fidalgo J, Martin-Vargas J, Pérez-Arnaiz C, Alonso-Torre SR, Biver T, Espino G, Busto N, García B. Biological activity and photocatalytic properties of a naphthyl-imidazo phenanthroline (HNAIP) ligand and its [Ir(ppy)2(HNAIP)]Cl and [Rh(ppy)2(HNAIP)]Cl complexes. J Inorg Biochem 2020;203:110885. [PMID: 31731049 DOI: 10.1016/j.jinorgbio.2019.110885] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
19 Zhang C, Guan R, Liao X, Ouyang C, Rees TW, Liu J, Chen Y, Ji L, Chao H. A mitochondria-targeting dinuclear Ir-Ru complex as a synergistic photoactivated chemotherapy and photodynamic therapy agent against cisplatin-resistant tumour cells. Chem Commun (Camb) 2019;55:12547-50. [PMID: 31576841 DOI: 10.1039/c9cc05998a] [Cited by in Crossref: 25] [Cited by in F6Publishing: 33] [Article Influence: 8.3] [Reference Citation Analysis]
20 Schur J, Lüning A, Klein A, Köster RW, Ott I. Platinum alkynyl complexes: Cellular uptake, inhibition of thioredoxin reductase and toxicity in zebrafish embryos. Inorganica Chimica Acta 2019;495:118982. [DOI: 10.1016/j.ica.2019.118982] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
21 Zhang W, Wang Y, Du F, He M, Gu Y, Bai L, Yang L, Liu Y. Evaluation of anticancer effect in vitro and in vivo of iridium(III) complexes on gastric carcinoma SGC-7901 cells. European Journal of Medicinal Chemistry 2019;178:401-16. [DOI: 10.1016/j.ejmech.2019.06.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 37] [Article Influence: 9.3] [Reference Citation Analysis]
22 Matos CP, Adiguzel Z, Yildizhan Y, Cevatemre B, Onder TB, Cevik O, Nunes P, Ferreira LP, Carvalho MD, Campos DL, Pavan FR, Pessoa JC, Garcia MH, Tomaz AI, Correia I, Acilan C. May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents? European Journal of Medicinal Chemistry 2019;176:492-512. [DOI: 10.1016/j.ejmech.2019.04.070] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 4.7] [Reference Citation Analysis]
23 Zhang H, Xie F, Cheng M, Peng F. Novel Meta-iodobenzylguanidine-Based Copper Thiosemicarbazide-1-guanidinomethylbenzyl Anticancer Compounds Targeting Norepinephrine Transporter in Neuroblastoma. J Med Chem 2019;62:6985-91. [DOI: 10.1021/acs.jmedchem.9b00386] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
24 Swaminathan S, Haribabu J, Kalagatur NK, Konakanchi R, Balakrishnan N, Bhuvanesh N, Karvembu R. Synthesis and Anticancer Activity of [RuCl26-arene)(aroylthiourea)] Complexes-High Activity against the Human Neuroblastoma (IMR-32) Cancer Cell Line. ACS Omega 2019;4:6245-56. [PMID: 31459766 DOI: 10.1021/acsomega.9b00349] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 13.7] [Reference Citation Analysis]
25 Jin J, Hu J, Qin Y, Zhang J, Zhao J, Yue L, Hou H. In vitro and in vivo anticancer activity of a thiourea tripyridyl dinuclear Cu( ii ) complex. New J Chem 2019;43:19286-97. [DOI: 10.1039/c9nj03371h] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]